ANTIROBE 75MG/CAP ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ
ANTIROBE 75MG/CAP ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ
Authorised
- Clindamycin
Product identification
Medicine name:
ANTIROBE 75MG/CAP ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ
Active substance:
- Clindamycin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin75.00milligram(s)1.00Capsule
Pharmaceutical form:
-
Capsule, hard
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fareva Amboise
- Pfizer Pgm
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 38830/11-06-2008/K-0059202
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: